Enveric Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2010 | — | $-49.5K | $1.1K |
| FY2011 | — | $4.6K | $18.2K |
| FY2012 | — | $-20.1K | $1.4K |
| FY2013 | — | $-20.2K | $249 |
| FY2014 | — | $424.6K | $374.7K |
| FY2015 | — | $972.9K | $825.6K |
| FY2016 | $1.5M | $11.7M | $1.4M |
| FY2017 | $1.1M | $19.4M | $4.9M |
| FY2018 | $0 | $-65.5K | $1.4M |
| FY2019 | $740.3K | $13.2M | $431.4K |
| FY2020 | — | $3.4M | $1.6M |
| FY2021 | — | $22.3M | — |
| FY2022 | — | $14.7M | — |
| FY2023 | — | $2.0M | — |
| FY2024 | — | $1.6M | — |
| FY2025 | — | $4.2M | — |